Advertisement

Aveir Leadless Pacemaker: Novel Technology With New Anesthetic Implications

      The Aveir VR Leadless Pacemaker (Abbott, Chicago, IL) recently was approved by the US Food and Drug Administration, and joined the Micra (Medtronic, Minneapolis, MN) transcatheter pacing system in the realm of nontransvenous cardiovascular implantable devices. The Aveir VR offers design improvements over its predecessor, the Nanostim (St. Jude Medical). There are recommendations for the perioperative management of conventional transvenous pacemakers, but leadless pacemakers add a new layer of consideration. Although there have been prior documented experiences with the Micra device, there are enough differences between the Aveir VR and the Micra that it is important to understand what makes the Aveir VR unique if an anesthesiologist were to come across one preoperatively.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Cardiothoracic and Vascular Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Mond HG
        • Proclemer A.
        The 11th world survey of cardiac pacing and implantable cardioverter-defibrillators: Calendar year 2009–a World Society of Arrhythmia's project.
        Pacing Clin Electrophysiol. 2011; 34: 1013-1027
        • Spickler JW
        • Rasor NS
        • Kezdi P
        • et al.
        Totally self-contained intracardiac pacemaker.
        J Electrocardiol. 1970; 3: 325-331
        • Lakkireddy D
        • Knops R
        • Atwater B
        • et al.
        A worldwide experience of the management of battery failures and chronic device retrieval of the Nanostim leadless pacemaker.
        Heart Rhythm. 2017; 14: 1756-1763
        • Richter S
        • Döring M
        • Ebert M
        • et al.
        Battery malfunction of a leadless cardiac pacemaker: Worrisome single-center experience.
        Circulation. 2018; 137: 2408-2410
      1. Abbott. Urgent field safety notice: Docking button detachment in Nanostim leadless cardiac pacemaker. Available at: https://www.cardiovascular.abbott/content/dam/bss/divisionalsites/cv/pdf/reports/Nanostim_Field_Safety_Notice_14Nov2017.pdf. Accessed May 23, 2022.

      2. United States Food and Drug Administration. Summary of safety and effectiveness data (Aveir VR Leadless System). Available at: https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P150035. Accessed May 23, 2022.

        • Reddy VY
        • Exner DV
        • Doshi R
        • et al.
        Primary results on safety and efficacy from the LEADLESS II-phase 2 worldwide clinical trial.
        JACC Clin Electrophysiol. 2022; 8: 115-117
      3. Medtronic. Micra VR manual. Available at: https://manuals.medtronic.com/manuals/main/. Accessed May 23, 2022.

      4. Abbott. Aveir Help Manual. Available at: https://manuals.sjm.com/?ct=professional. Accessed May 23, 2022.

      5. Abbott. Aveir Instructions for Use. Available at: https://manuals.sjm.com/?ct=professional. Accessed 23 May 2022.

        • Essandoh M
        • Dimitrov T
        • Elhassan A
        • et al.
        An echodensity in the right ventricle of a patient with a leadless pacemaker: Is it pathologic?.
        J Cardiothorac Vasc Anesth. 2019; 33: 2358-2359
        • Karuppiah S
        • Prielipp R
        • Banik RK.
        Anesthetic consideration for patients with micra leadless pacemaker.
        Ann Card Anaesth. 2020; 23: 493-495
        • Berrio Valencia MI
        • Kee C
        • Guo LR
        • et al.
        Temperature-related tachycardia during rewarming from hypothermic cardiopulmonary bypass in a patient with a leadless cardiac pacemaker.
        Can J Anaesth. 2018; 65: 854-855
        • Breeman KTN
        • du Long R
        • Beurskens NEG
        • et al.
        Tissues attached to retrieved leadless pacemakers: Histopathological evaluation of tissue composition in relation to implantation time and complications.
        Heart Rhythm. 2021; 18: 2101-2109
        • Satoh T
        • Fukui A
        • Katoh S
        • et al.
        A leadless pacemaker which became encapsulated only two months after placement.
        Intern Med. 2018; 57: 3053-3054
        • Tjong FV
        • Stam OC
        • van der Wal AC
        • et al.
        Postmortem histopathological examination of a leadless pacemaker shows partial encapsulation after 19 months.
        Circ Arrhythm Electrophysiol. 2015; 8: 1293-1295